...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: The waiting game.....
5
Jan 11, 2019 11:09AM
2
Jan 11, 2019 01:16PM
3
Jan 11, 2019 01:35PM
5
Jan 15, 2019 11:18AM
4
Jan 15, 2019 12:16PM
4
Jan 17, 2019 10:31AM
1
Jan 17, 2019 11:37AM
3
Jan 17, 2019 11:45AM
2
Jan 17, 2019 01:23PM
1
Jan 17, 2019 01:57PM
5
Jan 23, 2019 10:41PM
2
Jan 24, 2019 09:37AM
3
Jan 24, 2019 09:52AM
6
Feb 04, 2019 11:34AM
2
Feb 04, 2019 12:03PM
3
Feb 04, 2019 12:48PM
2
Feb 04, 2019 03:21PM
2
Feb 04, 2019 03:27PM
2
Feb 04, 2019 04:23PM
1
Feb 04, 2019 04:25PM
1
Feb 12, 2019 02:38PM
1
Feb 12, 2019 02:56PM
2
Feb 12, 2019 03:02PM
3
Feb 12, 2019 03:35PM
3
Feb 12, 2019 03:46PM
2
Feb 12, 2019 04:08PM
2
Feb 12, 2019 04:12PM
2
Feb 12, 2019 04:22PM
2
Feb 12, 2019 05:09PM
3
Feb 12, 2019 05:53PM
3
Feb 12, 2019 06:23PM
5
Feb 12, 2019 06:39PM
3
Feb 12, 2019 07:46PM
5
Feb 12, 2019 08:29PM
4
Feb 13, 2019 05:09AM
3
Feb 13, 2019 06:53AM

Yes, I understood that to be the case as has been talked about here. They did not list the January 2019 presentation on the Investor's page so I missed it.

What is the upside of continuing dosing patients for such length in time when as has been mentioned that events generally happen at the front end of the trial? Or am I wrong?

 

Koo 

2
Feb 13, 2019 09:20AM
5
Feb 13, 2019 10:22AM
Share
New Message
Please login to post a reply